170 related articles for article (PubMed ID: 19633811)
1. Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer-407-induced hyperlipidaemic rats.
Vaidya H; Rajani M; Sudarsanam V; Padh H; Goyal R
J Nat Med; 2009 Oct; 63(4):437-42. PubMed ID: 19633811
[TBL] [Abstract][Full Text] [Related]
2. Swertiamarin: a lead from Enicostemma littorale Blume. for anti-hyperlipidaemic effect.
Vaidya H; Rajani M; Sudarsanam V; Padh H; Goyal R
Eur J Pharmacol; 2009 Sep; 617(1-3):108-12. PubMed ID: 19577561
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of STZ-induced type 1 diabetic nephropathy by aqueous extract of Enicostemma littorale Blume and swertiamarin in rats.
Sonawane RD; Vishwakarma SL; Lakshmi S; Rajani M; Padh H; Goyal RK
Mol Cell Biochem; 2010 Jul; 340(1-2):1-6. PubMed ID: 20229291
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced β-cell damage in Wistar rat pancreas.
Dhanavathy G
J Endocrinol Invest; 2015 Jun; 38(6):669-84. PubMed ID: 25770453
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant and hepatoprotective effect of swertiamarin from Enicostemma axillare against D-galactosamine induced acute liver damage in rats.
Jaishree V; Badami S
J Ethnopharmacol; 2010 Jul; 130(1):103-6. PubMed ID: 20420896
[TBL] [Abstract][Full Text] [Related]
6. Isolation, characterization and antihyperlipidemic activity of secoisolariciresinol diglucoside in poloxamer-407-induced experimental hyperlipidemia.
Zanwar AA; Hegde MV; Rojatkar SR; Sonawane KB; Rajamohanan PR; Bodhankar SL
Pharm Biol; 2014 Sep; 52(9):1094-103. PubMed ID: 24649910
[TBL] [Abstract][Full Text] [Related]
7. Swertiamarin and quercetin combination ameliorates hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced type 2 diabetes mellitus in wistar rats.
Jaishree V; Narsimha S
Biomed Pharmacother; 2020 Oct; 130():110561. PubMed ID: 32795923
[TBL] [Abstract][Full Text] [Related]
8. Antiedematogenic and free radical scavenging activity of swertiamarin isolated from Enicostemma axillare.
Vaijanathappa J; Badami S
Planta Med; 2009 Jan; 75(1):12-7. PubMed ID: 19006050
[TBL] [Abstract][Full Text] [Related]
9. Hypolipidemic effects of Sophora flavescens and its constituents in poloxamer 407-induced hyperlipidemic and cholesterol-fed rats.
Kim HY; Jeong DM; Jung HJ; Jung YJ; Yokozawa T; Choi JS
Biol Pharm Bull; 2008 Jan; 31(1):73-8. PubMed ID: 18175945
[TBL] [Abstract][Full Text] [Related]
10. The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic Effects.
Patel N; Tyagi RK; Tandel N; Garg NK; Soni N
Curr Drug Targets; 2018; 19(16):1958-1967. PubMed ID: 29623834
[TBL] [Abstract][Full Text] [Related]
11. Analysis of swertiamarin in Swertia herb and preparations containing this crude drug by capillary electrophoresis.
Takei H; Nakauchi K; Yoshizaki F
Anal Sci; 2001 Jul; 17(7):885-8. PubMed ID: 11708124
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice.
Yang Y; Li J; Wei C; He Y; Cao Y; Zhang Y; Sun W; Qiao B; He J
Phytomedicine; 2019 Jun; 59():152782. PubMed ID: 31005808
[TBL] [Abstract][Full Text] [Related]
13. Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.
Muhamad Fadzil NS; Sekar M; Gan SH; Bonam SR; Wu YS; Vaijanathappa J; Ravi S; Lum PT; Dhadde SB
Drug Des Devel Ther; 2021; 15():2721-2746. PubMed ID: 34188450
[TBL] [Abstract][Full Text] [Related]
14. Antihyperlipidaemic effects of Eugenia jambolana fruit in diet induced hyperlipidaemic rats.
Bilal R; Zakaria M; Usman A; Aftab S; Zia A
J Pak Med Assoc; 2011 May; 61(5):433-7. PubMed ID: 22204172
[TBL] [Abstract][Full Text] [Related]
15. Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway.
Pandey T; Shukla A; Trivedi M; Khan F; Pandey R
Bioorg Chem; 2021 Mar; 108():104655. PubMed ID: 33548732
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases.
Leong XY; Thanikachalam PV; Pandey M; Ramamurthy S
Biomed Pharmacother; 2016 Dec; 84():1051-1060. PubMed ID: 27780133
[TBL] [Abstract][Full Text] [Related]
17. Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats.
Yoon NY; Kim HR; Chung HY; Choi JS
Arch Pharm Res; 2008 Dec; 31(12):1564-71. PubMed ID: 19099225
[TBL] [Abstract][Full Text] [Related]
18. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
Patel TP; Rawal K; Soni S; Gupta S
Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive activity of swertiamarin isolated from Enicostemma axillare.
Jaishree V; Badami S; Rupesh Kumar M; Tamizhmani T
Phytomedicine; 2009 Mar; 16(2-3):227-32. PubMed ID: 19019644
[TBL] [Abstract][Full Text] [Related]
20. Bioactivity of secoiridoid glycosides from Centaurium erythraea.
Kumarasamy Y; Nahar L; Cox PJ; Jaspars M; Sarker SD
Phytomedicine; 2003 May; 10(4):344-7. PubMed ID: 12809366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
